Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Danish brewing giant Carlsberg files IPO papers for India unit - livemint.com
Danish brewing giant Carlsberg files IPO papers for India unitlivemint.com

Danish brewing giant Carlsberg files IPO papers for India unit
Danish brewing giant Carlsberg has confidentially filed draft papers with markets regulator Sebi for an initial public offering (IPO) of its Indian business, people familiar with the development said on Thursday.
Danish brewer Carlsberg files for India unit IPO - Reuters
Danish brewer Carlsberg files for India unit IPOReuters
Shantha Biologics to make injectable drug cartridges for Novo Nordisk
Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable medicines at its Hyderabad facility. This partnership highlights India's growing role in advanced pharmaceutical manufacturing, particularly for high-demand diabetes and obesity therapies. Shantha's FDA-approved, automated fill-finish lines will produce these critical components, underscoring the company's expanding capabilities in contract manufacturing for biologics.
Arohan Financial Services files IPO papers; eyes ₹600 cr via fresh issue
Microfinance institution Arohan Financial Services has filed preliminary papers with market regulator Sebi to raise funds through an initial public offering (IPO), comprising a fresh issue of shares worth Rs 600 crore. Apart from the fresh issue, there will be an offer for sale (OFS) of4.04 crore shares by existing investors, according to the draft red herring prospectus (DRHP) filed with Sebi. US Teachers Insurance and Annuity Association, a retirement financial services firm, Michael & Susan Dell Foundation,Aavishkaar Goodwell India Microfinance Development Company-II Ltd,Tano Capital, TR Capital III Mauritius, and Danish Sustainable Development Goals Investment Fund,among other existing investors, will offload shares. Proceeds from the fresh issue will be used to boost the company's capital base and for general corporate purposes, the draft papers filed last week showed. Earlier in January, Arohan Financial Services Managing Director Manoj Kumar Nambiar stated that the company .

Race for AI-developed drugs heats up: Wegovy-maker Novo Nordisk ties up with OpenAI after rival Eli Lilly seals deal
Danish drugmaker Novo Nordisk is partnering with ChatGPT's parent company, OpenAI, to bring ‘better treatment options’ for patients. The development comes as pharma companies are increasingly relying on AI to boost R&D and operations.